COLON-MD: Colon Cancer Longitudinal Study
Start Date
2/1/2021
Completion Date
6/1/2026
Summary
The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
Detailed Description
In this longitudinal observational study patients will supply samples of their gut microbiome prior to scheduled colonoscopy or surgery along with dietary intake and blood samples; the relative abundance of microbes from those samples along with dietary data will be used to predict the presence or absence and severity of chemotherapy-induced diarrhea. Microbiome and diet based predictions from blinded samples will be combined to map the diet-microbiome changes during treatment to the changes in immune markers and risk of chemotherapy-induced diarrhea.
Eligibility Criteria
Age Range: 18 years to 79 years
Conditions
Locations
Baylor Research Institute
Temple, Texas 76508
United States